RTI Newsroom

MD/PhD student Jillian Belgrad has received an award from the National Institute of Neurological Disorders and Stroke to study the pathology that drives the development of Huntington’s disease symptoms.  

In a one-on-one interview, Terence R. Flotte shares what inspired him to pursue a career in medicine and what he’s learned in his role as provost and dean of the T.H. Chan School of Medicine at UMass Chan.

Seven women were honored for career achievements in science and health care during the 23rd annual Women’s Faculty Awards at UMass Chan Medical School.

Phillip D. Zamore, PhD, is one of 120 newly elected members of the National Academy of Sciences who were recognized for distinguished achievements in original research. Dr. Zamore is credited with identifying the biochemical machinery responsible for RNA silencing.

Katherine Fitzgerald, PhD, and Phillip D. Zamore, PhD, were elected to the American Academy of Arts & Sciences, which honors excellence and leaders from every field of human endeavor to examine new ideas, address issues of importance to the nation and the world, and work together to cultivate every art and science.

A multidisciplinary team of UMass Chan scientists has developed a technology for delivering siRNA molecules locally to lung tissue, providing the first evidence of a platform capable of delivering chemically modified siRNAs to the lungs nasally and achieving robust genetic silencing.

Athma A. Pai, PhD, was awarded a nearly $1 million CAREER grant from the National Science Foundation to use new high-throughput genomics approaches to study the regulation of mRNA splicing.

Sisters Ashley Craig and Lacey Foley joined the UMass ALS Cellucci Fund Boston Marathon team in memory of their grandmother. Brothers Dean and Zack Kennedy, PhD’19, are running on the Jake Kennedy ALS Fund team, in honor of their father.

UMass Chan Medical School has licensed siRNA chemistries developed by Julia Alterman, PhD, to Aldena Therapeutics for clinical development for dermatological diseases.

PhD candidate David Keener has received a National Institutes of Health grant to fund his research project on Rett syndrome, a genetic neurodevelopmental disease generally diagnosed in girls ages 6 to 18 months.